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Adiponectin isoneof themostclinically relevantcytokinesassociatedwithobesity.However, circadian
rhythmicity of adiponectin in humanadipose tissue (AT) has not been analyzed. To assesswhether the
mRNA levels of adiponectin and its receptors (ADIPOR1 and ADIPOR2) might show daily circadian
rhythms in visceral and sc fat explants obtained frommorbid obesewomen, visceral and sc abdominal
AT biopsies (n  6) were obtained from morbidly obese women (body mass index 40 kg/m2). An-
thropometric variables were measured and fasting plasma glucose, lipid, and lipoprotein concentra-
tions were analyzed. To investigate rhythmic expression pattern, AT explants were cultured during
24 h, and gene expression was analyzed at the following times: 0800, 1400, 2000, and 0200 h, using
quantitative real-time PCR. All genes investigated showed a circadian rhythmicity and oscillated ac-
curatelyand independentlyof the suprachiasmaticnucleus inbothATexplants (P0.05).Adiponectin
geneexpressionfluctuatedinthesamephaseas its receptors.Correlationanalysesbetweenthegenetic
circadian oscillation and components of the metabolic syndrome revealed that adiposity and abdominal
obesity correlatedwith a decrease in adiponectin and adiponectin receptorsADIPOR1 andADIPOR2 am-
plitude(P0.05).VisceralfatshowedatrendtowardaphasedelayanddampeningofthemRNAamplitude
ofadiponectinascomparedwithscfat.ThemRNAexpressionofadiponectinanditsreceptorsshowed24-h
rhythmicity in human AT frommorbidly obese patients. (Endocrinology 151: 115–122, 2010)
Metabolic syndrome (MetS) is becoming a majorhealth challenge, with a quarter of the world adult
population displaying one or more of its individual com-
ponents. However, despite its widespread presence, the
identification of its underlying causes continues to be a
challenge. Recently some studies suggested that the dis-
ruptionof the circadian system (chronodisruption)maybe
associated with manifestations of MetS (1). Thus, shift
work, sleep deprivation, and exposure to bright light at
night increase the prevalence of adiposity and MetS (2).
These discoveries have resulted in new paradigms regard-
ing the involvement of the circadian system in the regula-
tion of multiple pathophysiological disturbances (2).
One of the most exciting recent findings in the area of
chronobiology is that circadian clock genes exist in not
only thebrainbut alsoperipheral tissues relevant to energy
metabolism and cardiovascular functions, including the
heart, liver, pancreas, and adipose tissue (3–5).
Adipose tissue (AT), present in several peripheral de-
pots, acquires special relevance in the study of obesity and
MetS. It is now known that AT is not a mere inert storage
for triglycerides. In fact, adipocytes are currently seen as a
dynamic endocrine cell type, releasing free-fatty acids, and
secreting a number of factors or adipokines (6). The pres-
enceof active circadian clockmechanisms in this tissuehas
been recently published, and its periodic nature has been
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confirmed (5, 7). The persistency of gene expression os-
cillations in vitro strongly suggests the existence of an in-
tracellular circadian clock system directly regulating local
cell functions.
In this context, adiponectin is one adipokine that has
recently attractedmuch attention because it functions as a
keymodulator of insulin sensitivity (8, 9) and a protective
factor against MetS alterations (10, 11). The beneficial
effects of this hormone are predominantly mediated by
binding to two cell membrane receptors, adiponectin re-
ceptor (ADIPOR)-1 and ADIPOR2 (12). ADIPOR1, a
high-affinity receptor for globular adiponectin but a low-
affinity receptor for full-length adiponectin, is most abun-
dantly expressed in muscle, whereas ADIPOR2, an inter-
mediate-affinity receptor for both full-length and globular
adiponectin, is predominantly expressed in liver (12).
Both receptors are also present in adipose tissue, suggest-
ing that adiponectin may have biological effects in AT in
an autocrine/paracrine manner (13).
The diurnal and ultradiurnal dynamics of circulating
adiponectin concentrations have been demonstrated in
humans (14) and also in AT from experimental animals
(15).However, it remains to be characterizedwhether this
cytokine exerts a circadian oscillation in human adipose
tissue andwhether this oscillation differs between visceral
and subcutaneous fat depots.
In view of the above mentioned, the objective of the
present research was to analyze in human adipose tissue the
putativecircadianrhythmicityof theexpressionofadiponec-
tin and its two receptors, ADIPOR1 and ADIPOR2, as well
as to assess the potential differences between two adipose
depots, sc and visceral AT, in morbid obese female subjects.
Materials and Methods
Subjects
Visceral and sc abdominal AT biopsies were obtained from
morbidly obese women (n 6), aged 51 9 yr with body mass
index (BMI) 44.1 5.5 kg/m2, undergoing laparoscopic gastric
bypass surgery due to obesity at the General Surgery Service of
Virgen de la Arrixaca Hospital (Murcia, Spain). The women
studied were postmenopausal and were not under hormone re-
placement therapy. The day before surgery, all patients were
synchronizedhaving lunchat 1430anddinner at 2100h.TheAT
biopsies were taken as paired samples from the two AT depots
(visceral and sc) at the beginning of the surgical procedure (es-
timated time of biopsies sampling at 1300 h).
The protocols were approved by the Ethics Committee of the
Virgen de la Arrixaca University Hospital, and the subjects
signed a written informed consent before the biopsies were
obtained.
Clinical characteristics
Arterial pressure, BMI, andwaist and hip circumferencewere
assessed by standard procedures, whereas skinfolds (biceps, tri-
ceps, suprailiac, and subscapular) were measured with a Harp-
enden caliper (Holtain Ltd., Bryberian, Crymmych, Pem-
brokeshire, UK). Total body fat (percent) was evaluated by
bioimpedance with a TBF-300 (Tanita Corp. of America, Ar-
lington Heights, IL). Sagittal diameter and coronal diameter
weremeasured at the level of the iliac crest (L4-5) using aHoltain
Kahn abdominal caliper. Women were classified in visceral and
sc obesity calculating the index visceral area (VA)/sc area (SA)
after applying the following equation (16): VA/SApredicted 
0.868  0.064  sagittal diameter  0.036  coronal diame-
ter  0.022  triceps skinfold. Those patients with VA/SA
greater than 0.42were classified as having visceral obesity. Fast-
ing plasma concentrations of glucose, triacylglycerols, total cho-
lesterol, and high-density lipoprotein cholesterol were deter-
mined with commercial kits (Roche Diagnostics GmbH,
Mannheim, Germany).
Adipose tissue culture
Immediately after the surgery, a part of AT biopsies were
immediately frozen at 80 C and used for analyzing the basal
gene expression. The rest of AT was used for culture; thus, 800-
1000 mg AT explants (minimal pieces of 1–2 mm3 to allow the
maximal contact of adipose tissue with the medium) were trans-
ferred to cell culture bottles with membrane filter screw cap to
safeguard the viability of the culture and placed in 5 ml of
DMEM supplemented with 10% fetal bovine serum and kept at
37 C for 24 h in a humidified atmosphere containing 7% CO2.
On the next day, the adipose explants were collected to per-
formgene expression analysis at the following times (T): 0, 6, 12,
and 18, T0 being arbitrarily defined as 0800 h because this was
the usual waking time for patients, T6 as 1400 h, T12 as 2000 h,
and T18 as 0200 h. Gene expression was measured for only one
circadian cycle (24 h) but in the second day of cultured. All
cultures were performed in duplicates.
Analysis of gene expression
TotalRNAwas extracted fromATexplants usingRNeasy kit
(QIAGEN, Courtabeouf, France). Reverse transcription was
performedusing randomhexamers as primers andThermoscript
reverse transcriptase (Invitrogen, Cergy Pontoise, France)with 1
g total RNA for each sample. Quantitative real-time PCR was
performed using an ABI PRISM 7000 HT sequence detection
system (Applied Biosystems, Foster City, CA), using TaqMan
universal PCR master mix and specific TaqMan probes (Ap-
plied Biosystems). The primers used in the study are the fol-
lowing references from Applied Biosystems: human AdipoQ
(Hs00605917_m1),ADIPOR1(Hs01114951_m1)andADIPOR2
(Hs00226105_m1).We used 18S rRNA (referenceHs99999901_s1;
AppliedBiosystems) as internal control.We selected18Sbecause
this gene showed a lower variance along time comparedwith the
glyceraldehyde-3-phosphate dehydrogenase gene. In addition,
we carried out a one-way (Zeitgeber time) ANOVA for 18S and
observed no significant difference in any of the adipose depots
studied (P  0.05). In addition, there was no significant differ-
ence in 18S cycle threshold (Ct) between sc (mean Ct  23.3 
3.3) and visceral depots (mean Ct 23.2 3.3). In conclusion,
we selected 18S as the better housekeeping gene for this ex-
periment. GenemRNA levelswere normalized to 18s using the
2Ct method (17).
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Rhythm calculation and statistical analysis
Clinical and anthropometric data are presented as means 
SD. The results for gene expression, expressed in arbitrary units,
are presented as means  SEM. Wilcoxon nonparametric paired
test was used for comparing data from the samples derived from
the two adipose depots in each individual subject. Pearson’s cor-
relations coefficients were used for analyzing associations be-
tween the relative expression of adiponectin andADIPOR1 and
ADIPOR2 in both adipose depots.
The single cosinor method was used to analyze for circadian
rhythm individually (18). This inferential method involves fitting a
curve of a predefined period by the least squares method. The
rhythm characteristics and their 95% confidence intervals esti-
mated by this method include the mesor (middle value of the fitted
cosine representing a rhythm adjusted mean), the amplitude (half
the difference between the minimum and maximum of the fitted
cosine function), and the temporal location of maximum value or
acrophase (the timeatwhichthepeakofarhythmoccurs, expressed
in hours) and the percent rhythm (PR; percentage of variability
accountedforbycosinecurve).Relativeamplitudewasexpressedas
a percentage of mesor values [relative amplitude  (amplitude/
mesor) 100]. The significance of the rhythmswas determined by
rejectionof thezeroamplitudehypotheseswitha thresholdof60%.
Meancircadiangeneexpressionofthetotalpopulationintoeach
fat depot was analyzed by using repeated-measures ANOVA test,
with a post hoc test of least significant difference (LSD) correction.
Differences in acrophase between sc and visceral depots were an-
alyzed by Mann-Whitney nonparametric test for the three genes
studied. Pearson’s correlation analyses were used for finding asso-
ciations between the genetic circadian oscillation (amplitude) and
componentsof theMetS.All statistical analyseswerecarriedoutusing
SPSS forWindows (release 15.0; SPSS Inc., Chicago, IL). The level of
significance for all statistical tests and hypotheseswas set atP 0.05.
Results
Characteristics of the population
Table 1 contains basal characteristics of the women
studied. BMI was higher than 40 kg/m2 in these patients
and VA/SA higher than 0.4, indicating that women suf-
fered from visceral and morbid obesity. All subjects were
defined as MetS patients, according to the International
Diabetes Federation (IDF) criteria (19). The individual
and average values for waist circumference, glucose, and
systolic pressure exceeded the cutoff points proposed by
the IDF (Table 2).
Basal gene expression
Paired adipose tissue biopsies from the sc and visceral
depots were obtained from each patient. Attending to
basal gene expression, significant differences in adiponec-
tin were observed between AT depots (Fig. 1), with a
higher expression in sc than visceral fat, whereas no
significant differences were found in the relative expres-
sion of both adiponectin receptors, ADIPOR1 and
ADIPOR2,within each fat compartment (Fig. 1). Pearson’s
correlation analysis showed significant positive correla-
tions among adiponectin and ADIPOR1 and ADIPOR2
in sc (ADIPOQ vs. ADIPOR1: P  0.039, r  0.834;
ADIPOQ vs. ADIPOR2: P  0.036, r  0.841;
ADIPOR1 vs. ADIPOR2: P  0.033, r  0.848) and
visceral AT (ADIPOQ vs. ADIPOR1: P  0.010, r 
0.915; ADIPOQ vs. ADIPOR2: P  0.000, r  0.989;
ADIPOR1 vs. ADIPOR2: P 0.008, r 0.927).
Circadian gene expression
Once we examined the basal expression of these genes,
we focused on their circadian expression pattern in cul-
tured adipose tissue explants. Parameters imputed from
each subject obtained by cosinor analysis, defining the
circadian rhythms as mesor, amplitude, relative ampli-
tude, acrophase, and percent rhythmare reported inTable
3. According to these results, circadian expression pat-
ternswere found for all the genes investigated (represented
in bold).
Figure 2 shows mean circadian rhythms for the exam-
ined group concerning the three genes studied (ADIPOQ,
ADIPOR1, and ADIPOR2) in sc (Fig. 2A) and visceral
TABLE 1. Anthropometric characteristics of the
population studied
Patients (n  6)
Age (yr) 51  9
Weight (kg) 107.9  11.2
Height (cm) 156  5.0
BMI (kg/m2) 44.1  5.5
Body fat (%) 43  6
WC (cm) 126  8
HC (cm) 139  9
WHR 0.91  0.03
Sagittal diameter (cm) 22  4
Coronal diameter (cm) 31  4
Bicipital sinkfold (mm) 28  3
Tricipital sinkfold (mm) 28  4
Subscapular sinkfold (mm) 33  4
Suprailliac sinkfold (mm) 31  3
VA/SApredicted 0.54  0.28
Data are presented as means  SD. WC, Waist circumference; HC, hip
circumference.
TABLE 2. MetS characteristics of the subjects studied
Patients
(n  6)
IDF MeS
worldwide
definition
WC (cm) 126  8 80
Plus any two of the following
Triglycerides (mmol/liter) 1.02  0.42 1.70
HDL cholesterol (mmol/liter) 1.34  0.22 1.29
Glucose (mmol/liter) 6.13  0.82 5.60
Systolic pressure (mm Hg) 148  23 130
Diastolic pressure (mm Hg) 73  14 85
Data are presented as means  SD. Bold characters indicate values
higher than cutoff points proposed by the IDF (19). WC, Waist
circumference; HDL, high-density lipoprotein.
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AT (Fig. 2B). When relative gene expression among dif-
ferent times was analyzed by using repeated-measures
ANOVA test, statistical differences were found for ADIPOQ
insc (P0.010)andvisceral (P0.045)ATs,evidencingthe
circadian rhythmicity of adiponectin expression.
When comparing both AT depots, different circadian
patterns were observed. Thus, whereas the sc tissue dis-
played a strong oscillatory trend, adiponectin circadian
expression in visceral fat was dampened in all patients,
with only one exception, as observed when comparing
relative amplitude from both AT loca-
tions (Table 3). Moreover, the three
genes cycled in synchrony in both de-
pots, butwhile in sc adipose tissue, they
reached their zenith (highest levels)
around Zeitgeber time 0 (0800 h) and
their nadir (lowest levels) around time
12 (2000 h); in omental AT both zenith
andnadirwere significantly delayed6h
with respect to scAT for the three genes
studied (P  0.05).
Correlation analyses between the ge-
netic circadian oscillation (amplitude) and
components of the MetS revealed that
higher adiposity and abdominal obesity
(BMI, body fat percent, waist, sagittal di-
ameter,andconicity index)correlatedwith
a decrease in ADIPOQ, ADIPOR1, and
ADIPOR2 amplitude (Table 4).
A simple statistical analysis was performed correlating
the phase difference between both AT depots (differences
in achrophase from sc and visceral fat) in adiponectin ex-
pression and obesity parameters such as BMI, waist cir-
cumference, waist to hip ratio (WHR), and sagittal diam-
eter, and no significant associations were found for those
parameters (BMI: r  0.235, P  0.70; waist circumfer-
ence: r  0.62; P  0.26; WHR: r  0.09; P  0.89;
sagittal diameter r  0.08, P  0.89).
FIG. 1. Basal relative expression of genes studied (ADIPOQ, ADIPOR1, and ADIPOR2) in sc and
visceral adipose tissue. mRNA levels were measured with the real-time PCR and normalized to 18S
using the Ct method of relative quantitation. Data are reported as means SEM, and results
are presented as percent of ADIPOR2 relative expression (ADIPOR2 value 1). Asterisk represents
significant differences (Wilcoxon nonparametric paired test). NS, Not significant.
TABLE 3. Parameters imputed from cosinor analysis
SC AT Visceral AT
Patients
Mesor
(AU)
Amplitude
(AU)
Relative
amplitude
(%)
Acrophase
(h)
PR
(%)
Mesor
(AU)
Amplitude
(AU)
Relative
amplitude
(%)
Acrophase
(h)
PR
(%)
Adiponectin
P2 1.703 0.587 34.47 2.11 87.41 4.592 4.655 101.37 1.8 83.22
P3 2.856 2.59 90.69 1.72 93.71 2.923 1.25 42.76 8.8 43.21
P4 14.463 20.047 138.61 23.8 82.37 1.852 2.332 125.92 0.67 93.23
P5 7.098 10.754 151.51 0.1 63.05 3.301 3.323 100.67 11.76 55.86
P6 33.976 57.466 169.14 0.17 64.02 5.11 4.782 93.58 6.16 96.25
ADIPOR1
P1 3.637 3.517 96.70 9.5 99.61 1.76 1.122 63.75 10.27 91.1
P2 3.335 1.767 52.98 6.65 27.39 2.16 1.487 68.84 2.49 94.34
P3 1.935 1.384 71.52 7.1 86.19 1.38 0.53 38.41 10.77 75.63
P4 50.332 35.102 69.74 21.23 53.61 1.778 2.279 128.18 0.5 91.8
P5 14.171 2.467 17.41 22.04 2.08 3.242 3.225 99.48 10.69 79.6
P6 7.821 10.895 139.30 10.21 94.27 3.859 1.495 38.74 15.42 23.18
ADIPOR2
P1 3.021 2.749 91.00 8.16 97.69 2.862 2.205 77.04 11.39 51.52
P2 1.785 0.736 41.23 20.37 67.92 2.997 2.289 76.38 3.02 95.01
P3 2.668 1.607 60.23 8.53 88.9 1.645 0.615 37.39 10.66 50.15
P4 22.318 24.478 109.68 20.98 94.74 2.083 2.602 124.92 0.96 94.63
P5 7.414 2.933 39.56 0.02 9.5 3.718 4.548 122.32 11.24 75.69
P6 26.679 31.139 116.72 0.52 51.24 1.544 0.652 42.23 5.91 43.25
Parameters imputed from each subject obtained by cosinor analysis defining the circadian rhythms as mesor, amplitude, relative amplitude, acrophase, and PR are
represented in this table. Subjects in which expression of the gene was considered to have circadian rhythmicity are shown in bold. AU, Arbitrary units.
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Discussion
Adiponectin is one of most intensively studied cytokines.
The interest on this novel adipocyte hormone is mainly
derived from its protective role in the different alterations
associated with obesity, such as insulin resistance and in-
flammation (20). Interestingly, in humans, circulating adi-
ponectin levels exhibit diurnal variations (14). However,
as far as we know, specific information concerning circa-
dian rhythmic expression of this adipokine in human AT
has not been reported. In the present study,we show inAT
from obese women that adiponectin mRNA levels fluctu-
ate during the day in the same phase as its receptors and
that this circadian rhythmicity is attenuated with MetS
features.
Women from the present work displayed significant
differences in basal adiponectin expression between AT
depots, being higher in the sc expression. These findings
are in agreement with a previous study performed in a
FIG. 2. Rhythmic expression of genes studied in human sc (A) and
visceral AT (B). Adipose depots were isolated at 6-h intervals over the
course of the day from AT cultures (time at 0, 6, 12, and 18 h). Results
are presented relative to the lowest basal relative expression for each
gene. Data of relative expression are represented as arbitrary units
(AU). Data are reported as means  SEM (SEM of Ct are represented in
parentheses).
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similar population (21) and could be associated with the
cardioprotective feature of this adipose area, termed by
some authors as healthy adipose tissue (22). With respect
to adiponectin receptors, no significant differences were
found between both AT location, as previously shown in
experimental animals (23).
The main objective of the present work was to assess
whether themRNA levels of adiponectin and its receptors
showed daily circadian rhythms in visceral and sc fat ex-
plants obtained from morbidly obese women. Results in-
dicate that the threegenesexamined(ADIPOQ,ADIPOR1,
andADIPOR2) exhibited 24-h rhythmicity, suggesting that
the expression of adiponectin is regulated in a time-depen-
dent manner, at least at the mRNA level.
Thus, our data suggest that these genes can oscillate ac-
curatelyand independentlyof thesuprachiasmaticnucleus in
human AT during 24 h. This situation has been previously
demonstrated for other genes in humanAT cultures, such as
clockgenes (PER2,CRY1, andBMAL1) (7), cortisol-related
genes, such as glucocorticoid receptor (GR) and 11-hy-
droxysteroid dehydrogenase 1 (11HSD1), and PPAR
(24). However, this is the first study to show the circadian
expression of adiponectin and its receptors in human AT.
Froma physiological point of view, these newdata are not
surprising if we consider that, besides glucose and lipid
homeostasis, there aremanyhormones (insulin, glucagon,
GH, and cortisol) and adipose-specific molecules impli-
cated in energy metabolism andMetS (leptin, adipsin, re-
sistin, and visfatin), which display circadian oscillation
with different daily pattern (2).
Only a limited number of studies previously examined
ADIPOR expression in AT (13, 16, 25). Here we first
explore their circadian rhythmicity, finding that they fluc-
tuate in the same phase as adiponectin. This synergy could
magnify the physiological effect of adiponectin and facil-
itate its autocrine/paracrine action. Indeed, the simulta-
neous circadian expression of adiponectin and its recep-
tors may lead to an increase in adiponectin binding and
thus result in increased adiponectin effects. These results
emphasize the importance of circadian rhythmicity in the
physiological role of adiponectin.
A previous study performed in experimental animals
(26) have shown that adiponectin gene expression follows
a circadian rhythm in adipose tissue depots with a nadir
(minimum expression) during the morning (1000–1100
h). In the present study, performed in humans, the expres-
sion of adiponectin achieved its zenith (maximum) at the
same hours. As expected, circadian expression of human
adiponectin occurs in antiphase as compared with mice, a
rodent characterized by its nocturnal behavior.
In humans, there are no studies showing circadian adi-
ponectin gene expression in other tissues and none per-
formed in women or obese women. When comparing AT
adiponectin circadian expression in the presentworkwith
serumdiurnal variability fromapreviouswork (14), it can
be observed that the nadir in AT in the present paper an-
ticipated to that found in plasma, thus implying a 7-h
phase delay between the transcription and the secretion of
the protein to blood. These data must be discussed with
caution because the study by Gavrila et al. (14) was per-
formed in healthy males, whereas the present work is fol-
lowed up in morbidly obese women. However, these re-
sults could be explained by the kinetics of expression,
synthesis, and secretion of adiponectin.
Recent findings suggest that the circadian system reg-
ulates the metabolism in all tissues and organs implicated
in the pathological changes leading the MetS. Moreover,
glucose and lipid homeostasis are also known to exhibit
circadian variation (27–30). In this sense, adiponectin is
highly implicated in glucose metabolism (31). An addi-
tional relevant finding in our results was that adiponectin
expression was decreased in the late evening (2000 h),
which coincides with the hours of maximal insulin resis-
tance in humans (32). Additionally, adiponectin has been
called the fat-burning molecule because it is able to redi-
rect fatty acids to the muscle for their oxidation (31). This
special capability is of great interest because the influx of
fatty acids to the liver decreases and so does total triglyc-
eride content, leading to a higher insulin-sensitivity state
(31). The fact that adiponectin displays its higher expres-
sion during the morning hours (1000 h) could be impli-
cated in the maximal withdrawal of fatty acids at these
timesand the improvement inglucose tolerance,which char-
acterized the subjects in these particular daily hours (32).
Circadian disruption or chronodisruption is character-
ized by an attenuation of the circadian rhythms (33). Re-
cently some studies suggested that chronodisruption may
lead to obesity (1). Disrupted biological rhythms lead to
attenuated circadian feeding rhythms, hyperphagia, obe-
sity, cancer proneness, and reduced life expectancy (1). In
this regard, our correlation analyses performed between
the genetic circadian oscillation (amplitude) and compo-
nents of the MetS revealed that the rhythmicity of adi-
ponectin expression in the women studied was attenuated
with obesity. Indeed, our results show that an increase of
adiposity markers and mainly abdominal obesity (BMI,
body fat percent, weight, waist, sagittal diameter, and co-
nicity index) significantly correlated with a decrease in
adiponectin and ADIPOR1 and ADIPOR2 amplitude,
which characterized a dampened rhythm. It is important
to highlight that this situation was present only in the
visceral fat. Another interesting resultwas thatwhen com-
paring AT locations, visceral fat showed a trend toward a
dampening of the mRNA amplitude of components of
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adiponectin function, compared with sc fat. This consid-
erationperhapsmayhelp to explainwhyMetS features are
highly related to visceral fat. Previously Ando et al. (15)
showed that the rhythmic expression of clock genes
(Bmal1, Per1, Per2, Cry1, Cry2, and Dbp) and adipocy-
tokines (adiponectin, resistin, andvisfatin)wasattenuated
in visceral adipose tissue from obese KK mice. Other an-
imalmodels revealed thatmicewithClockgenedisruption
are prone to develop obesity and a phenotype resembling
MetS (34).
Another interesting characteristic that provides infor-
mation about rhythmicity in AT is the potential phase
delay between the different AT locations. In this line, in
visceral AT from the women studied, both nadir and ze-
nith were significantly delayed 6 h with respect to sc. A
similar situation was present for two of the clock genes
studied (hPer2 and hCry1) but not for hBmal1 (data not
shown). It is noteworthy that this phase delay between
both AT location was not related to obesity. Indeed, no
significant correlationswere obtainedbetweenobesity pa-
rameters and the differences in achrophase from both AT
locations. Interestingly, in humans, alterations in the dy-
namics of circulating adiponectin with obesity have also
been reported (35). Together with previous findings, we
could then speculate that circadian rhythm disruption is
clearly important in determining the severity of the met-
abolic impairment and vice versa (36).
One of the shortcomings of the current design is that it
includes only morbidly obese women, and more informa-
tion is needed about gender differences. Although in this
study adiposity was associated with chronodisruption,
even inmorbidly obesewomen, another aspect to consider
is whether the rhythms may be different for less obese
individuals. However, to obtain enough AT sample from
normal-weight individuals may be challenging, and it
could be also an ethical problem, considering the difficul-
ties in obtaining enough fat from visceral and sc locations
within the same patients to perform four different adipose
tissue explants cultures.
In conclusion, we have found for the first time that
expression of adiponectin and its receptors (ADIPOR1
and ADIPOR2) showed 24-h rhythmicity in human vis-
ceral and sc AT explants from morbid obese patients. In-
terestingly, this rhythmic adiponectin expression is in
phase with its receptors, and there is a zenith delay of 6 h
in omental AT with respect to sc fat.
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